These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 36705868)

  • 21. Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate.
    Shao J; Zaro J; Shen Y
    Int J Nanomedicine; 2020; 15():9355-9371. PubMed ID: 33262592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential applications of mesenchymal stem cells and their derived exosomes in regenerative medicine.
    Adelipour M; Lubman DM; Kim J
    Expert Opin Biol Ther; 2023; 23(6):491-507. PubMed ID: 37147781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine.
    Lopes D; Lopes J; Pereira-Silva M; Peixoto D; Rabiee N; Veiga F; Moradi O; Guo ZH; Wang XD; Conde J; Makvandi P; Paiva-Santos AC
    Mil Med Res; 2023 Apr; 10(1):19. PubMed ID: 37101293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapies.
    García-Fernández J; Fuente Freire M
    Cancer Lett; 2023 May; 561():216151. PubMed ID: 37001751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosome-based delivery nanoplatforms: next-generation theranostic platforms for breast cancer.
    Zheng Y; Li M; Weng B; Mao H; Zhao J
    Biomater Sci; 2022 Mar; 10(7):1607-1625. PubMed ID: 35188522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced Regenerative Medicine Strategies for Treatment of Perianal Fistula in Crohn's Disease.
    Nazari H; Naei VY; Tabasi AH; Badripour A; Akbari Asbagh R; Keramati MR; Sharifi A; Behboudi B; Kazemeini A; Abbasi M; Keshvari A; Ahmadi Tafti SM
    Inflamm Bowel Dis; 2022 Jan; 28(1):133-142. PubMed ID: 34291798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
    Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
    Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosome-loaded scaffolds for regenerative medicine in hard tissues.
    Rahmati S; Khazaei M; Nadi A; Alizadeh M; Rezakhani L
    Tissue Cell; 2023 Jun; 82():102102. PubMed ID: 37178527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs).
    Ke W; Afonin KA
    Adv Drug Deliv Rev; 2021 Sep; 176():113835. PubMed ID: 34144087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomes: the latest in regenerative aesthetics.
    Vyas KS; Kaufman J; Munavalli GS; Robertson K; Behfar A; Wyles SP
    Regen Med; 2023 Feb; 18(2):181-194. PubMed ID: 36597716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosome therapeutics for lung regenerative medicine.
    Popowski K; Lutz H; Hu S; George A; Dinh PU; Cheng K
    J Extracell Vesicles; 2020 Jun; 9(1):1785161. PubMed ID: 32944172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis.
    Wang J; Li W; Lu Z; Zhang L; Hu Y; Li Q; Du W; Feng X; Jia H; Liu BF
    Nanoscale; 2017 Oct; 9(40):15598-15605. PubMed ID: 28990632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the Ophthalmic Diseases Using Extracellular Vesicles 'Exosomes': Current Insights on Their Clinical Approval and Present Trials.
    Yu H; Wu J; Pan G
    Aging Dis; 2024 May; ():. PubMed ID: 38913038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plant-derived Exosomes: Pioneering Breakthroughs in Therapeutics, Targeted Drug Delivery, and Regenerative Medicine.
    Dutta S; Ghosh S; Rahaman M; Chowdhury SR
    Pharm Nanotechnol; 2024 Jun; ():. PubMed ID: 38840389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineering exosomes and biomaterial-assisted exosomes as therapeutic carriers for bone regeneration.
    Lu Y; Mai Z; Cui L; Zhao X
    Stem Cell Res Ther; 2023 Mar; 14(1):55. PubMed ID: 36978165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How can nanotechnology help membrane vesicle-based cancer immunotherapy development?
    Tian X; Zhu M; Nie G
    Hum Vaccin Immunother; 2013 Jan; 9(1):222-5. PubMed ID: 23108359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the Choice of the Extracellular Vesicles for Therapeutic Purposes.
    Campanella C; Caruso Bavisotto C; Logozzi M; Marino Gammazza A; Mizzoni D; Cappello F; Fais S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New advances in exosome-based targeted drug delivery systems.
    Ferreira D; Moreira JN; Rodrigues LR
    Crit Rev Oncol Hematol; 2022 Apr; 172():103628. PubMed ID: 35189326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological Inhibition of Exosome Machinery: An Emerging Prospect in Cancer Therapeutics.
    Syeda S; Rawat K; Shrivastava A
    Curr Cancer Drug Targets; 2022; 22(7):560-576. PubMed ID: 35366773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine.
    Hade MD; Suire CN; Suo Z
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.